Back to search

Dermal Diagnostics Limited

06795555

liquidation
Private Limited Company
Companies House
Health Score
N/A

Details

C/O R2 ADVISORY LIMITED, LONDON, EC4N 6NP
Incorporated 20/01/2009

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72190
Other research and experimental development on natural sciences and engineering

Officers

Mister Dewan Fazlul Hoque Chowdhury

director · Since 20/01/2009

DIRECTOR

BRITISH · ENGLAND · Age 53

Also on 13 other boards

Persons with Significant Control

Mister Dewan Fazlul Hoque Chowdhury

Significant control

British · England · Age 53

C/O R2 Advisory Limited, 60 Cannon Street, London, EC4N 6NP

Notified 06/04/2016

Charges1 outstanding

Charge
outstanding

CHICAGO VENTURE PARTNERS, L.P.

Created 14/09/2020Registered 10/10/2020
charge
satisfied

TRIAL CLINIC LIMITED

Created 27/09/2011Registered 13/10/2011Satisfied 04/08/2020

CompanyRankvs 15+ SIC 72190 peers
12

Financial strengthNo net worth data · 0/25
EmployeesNo employee data · 0/15
LiquidityCurrent ratio 0.27× · 2/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10Outstanding charges -10
Show leaderboard
1Kemet International Limited
90
2R.B. Radley & Company Limited
90
3Tom Martin & Company Limited
90
4Sra Developments Limited
90
5Drumgrange Limited
90
6Giro Engineering Limited
90
7Hydronix Limited
90
8Fluid Gravity Engineering Limited
90
9Innovative Technology Limited
90
10Scanna Msc Limited
90
How is this score calculated?
Financial strength0/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees0/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

ultimate parent company. The published audited financial statements of the ultimate parent company for the year ended 31 March 2023 confirm the auditors concern about its ability to continue as a going concern but also detail management’s plans in regard to such matters. It is on this basis the directors continue to adopt the going concern basis in preparing the financial statements. DERMAL DI

Key FinancialsYear ending 31/03/2023

Net Worth

-£31.6M

Balance sheet strength

Cash

£8.2M

Cash in the bank

Net Current Assets

-£28.8M

Working capital

Current Assets

£10.7M

Current Liabilities

£39.6M

Fixed Assets

£604k

Debtors

£1.1M

35avg. employees+6

Balance Sheet

Intangible assets£75k
Assets less current liabilities-£28.2M
Prepared with CCH Software

EstimatesDerived

YearCurrent RatioImplied Profit
20230.27-£12.1M
20220.43-£8.7M
20211.17-£3.0M
20200.06-£1.8M
20190.38—

Derived from filed accounts. Not audited figures.